Global and United States Biotechnological Drugs Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Biotechnological Drugs Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Biotechnological Drugs Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Biotechnological Drugs Market Size for the Year 2017-2028
  • 1.2.2 Global Biotechnological Drugs Market Size for the Year 2017-2028
• 1.3 Biotechnological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Biotechnological Drugs in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Biotechnological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Biotechnological Drugs Market Dynamics
  • 1.4.1 Biotechnological Drugs Industry Trends
  • 1.4.2 Biotechnological Drugs Market Drivers
  • 1.4.3 Biotechnological Drugs Market Challenges
  • 1.4.4 Biotechnological Drugs Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Biotechnological Drugs by Type

• 2.1 Biotechnological Drugs Market Segment by Type
  • 2.1.1 Genetically Engineered Drugs
  • 2.1.2 Therapeutic Monoclonal Antibody Drugs
  • 2.1.3 Gene Therapy and Nucleic Acid Drugs
  • 2.1.4 Genetically Engineered Vaccines
  • 2.1.5 Other
• 2.2 Global Biotechnological Drugs Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Biotechnological Drugs Market Size by Type (2017-2028)
• 2.4 United States Biotechnological Drugs Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Biotechnological Drugs Market Size by Type (2017-2028)

3 Biotechnological Drugs by Application

• 3.1 Biotechnological Drugs Market Segment by Application
  • 3.1.1 Tumor
  • 3.1.2 Autoimmune Disease
  • 3.1.3 Other
• 3.2 Global Biotechnological Drugs Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Biotechnological Drugs Market Size by Application (2017-2028)
• 3.4 United States Biotechnological Drugs Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Biotechnological Drugs Market Size by Application (2017-2028)

4 Global Biotechnological Drugs Competitor Landscape by Company

• 4.1 Global Biotechnological Drugs Market Size by Company
  • 4.1.1 Top Global Biotechnological Drugs Companies Ranked by Revenue (2021)
  • 4.1.2 Global Biotechnological Drugs Revenue by Player (2017-2022)
• 4.2 Global Biotechnological Drugs Concentration Ratio (CR)
  • 4.2.1 Biotechnological Drugs Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Biotechnological Drugs in 2021
  • 4.2.3 Global Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Biotechnological Drugs Headquarters, Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Biotechnological Drugs Headquarters and Area Served
  • 4.3.2 Global Biotechnological Drugs Companies Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Biotechnological Drugs Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Biotechnological Drugs Market Size by Company
  • 4.5.1 Top Biotechnological Drugs Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Biotechnological Drugs Revenue by Players (2020, 2021 & 2022)

5 Global Biotechnological Drugs Market Size by Region

• 5.1 Global Biotechnological Drugs Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Biotechnological Drugs Market Size by Region (2017-2028)
  • 5.2.1 Global Biotechnological Drugs Market Size by Region: 2017-2022
  • 5.2.2 Global Biotechnological Drugs Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.1.2 North America Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Biotechnological Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 3SBIO
  • 7.1.1 3SBIO Company Details
  • 7.1.2 3SBIO Business Overview
  • 7.1.3 3SBIO Biotechnological Drugs Introduction
  • 7.1.4 3SBIO Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.1.5 3SBIO Recent Development
• 7.2 Anhui Anke Biotechnology
  • 7.2.1 Anhui Anke Biotechnology Company Details
  • 7.2.2 Anhui Anke Biotechnology Business Overview
  • 7.2.3 Anhui Anke Biotechnology Biotechnological Drugs Introduction
  • 7.2.4 Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.2.5 Anhui Anke Biotechnology Recent Development
• 7.3 Beijing SL Pharmaceutical
  • 7.3.1 Beijing SL Pharmaceutical Company Details
  • 7.3.2 Beijing SL Pharmaceutical Business Overview
  • 7.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Introduction
  • 7.3.4 Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.3.5 Beijing SL Pharmaceutical Recent Development
• 7.4 Biotech Pharmaceutical
  • 7.4.1 Biotech Pharmaceutical Company Details
  • 7.4.2 Biotech Pharmaceutical Business Overview
  • 7.4.3 Biotech Pharmaceutical Biotechnological Drugs Introduction
  • 7.4.4 Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.4.5 Biotech Pharmaceutical Recent Development
• 7.5 Cadila Healthcare
  • 7.5.1 Cadila Healthcare Company Details
  • 7.5.2 Cadila Healthcare Business Overview
  • 7.5.3 Cadila Healthcare Biotechnological Drugs Introduction
  • 7.5.4 Cadila Healthcare Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.5.5 Cadila Healthcare Recent Development
• 7.6 Celgen Biopharma
  • 7.6.1 Celgen Biopharma Company Details
  • 7.6.2 Celgen Biopharma Business Overview
  • 7.6.3 Celgen Biopharma Biotechnological Drugs Introduction
  • 7.6.4 Celgen Biopharma Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.6.5 Celgen Biopharma Recent Development
• 7.7 Celltrion
  • 7.7.1 Celltrion Company Details
  • 7.7.2 Celltrion Business Overview
  • 7.7.3 Celltrion Biotechnological Drugs Introduction
  • 7.7.4 Celltrion Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.7.5 Celltrion Recent Development
• 7.8 Dr Reddy’s
  • 7.8.1 Dr Reddy’s Company Details
  • 7.8.2 Dr Reddy’s Business Overview
  • 7.8.3 Dr Reddy’s Biotechnological Drugs Introduction
  • 7.8.4 Dr Reddy’s Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.8.5 Dr Reddy’s Recent Development
• 7.9 GeneScience Pharmaceuticals
  • 7.9.1 GeneScience Pharmaceuticals Company Details
  • 7.9.2 GeneScience Pharmaceuticals Business Overview
  • 7.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Introduction
  • 7.9.4 GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.9.5 GeneScience Pharmaceuticals Recent Development
• 7.10 Hisun Pharma
  • 7.10.1 Hisun Pharma Company Details
  • 7.10.2 Hisun Pharma Business Overview
  • 7.10.3 Hisun Pharma Biotechnological Drugs Introduction
  • 7.10.4 Hisun Pharma Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.10.5 Hisun Pharma Recent Development
• 7.11 Jiangsu Sihuan Bioengineering
  • 7.11.1 Jiangsu Sihuan Bioengineering Company Details
  • 7.11.2 Jiangsu Sihuan Bioengineering Business Overview
  • 7.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Introduction
  • 7.11.4 Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.11.5 Jiangsu Sihuan Bioengineering Recent Development
• 7.12 Novartis (Sandoz)
  • 7.12.1 Novartis (Sandoz) Company Details
  • 7.12.2 Novartis (Sandoz) Business Overview
  • 7.12.3 Novartis (Sandoz) Biotechnological Drugs Introduction
  • 7.12.4 Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.12.5 Novartis (Sandoz) Recent Development
• 7.13 Pfizer (Hospira)
  • 7.13.1 Pfizer (Hospira) Company Details
  • 7.13.2 Pfizer (Hospira) Business Overview
  • 7.13.3 Pfizer (Hospira) Biotechnological Drugs Introduction
  • 7.13.4 Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.13.5 Pfizer (Hospira) Recent Development
• 7.14 Shanghai Lansheng Guojian Pharmaceutical
  • 7.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Details
  • 7.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
  • 7.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Introduction
  • 7.14.4 Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Development
• 7.15 Shenzhen Neptunus Interlong Bio-Technique
  • 7.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Details
  • 7.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
  • 7.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Introduction
  • 7.15.4 Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Development
• 7.16 Tonghua Dongbao Pharmaceutical
  • 7.16.1 Tonghua Dongbao Pharmaceutical Company Details
  • 7.16.2 Tonghua Dongbao Pharmaceutical Business Overview
  • 7.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Introduction
  • 7.16.4 Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.16.5 Tonghua Dongbao Pharmaceutical Recent Development
• 7.17 Torrent Pharmaceuticals
  • 7.17.1 Torrent Pharmaceuticals Company Details
  • 7.17.2 Torrent Pharmaceuticals Business Overview
  • 7.17.3 Torrent Pharmaceuticals Biotechnological Drugs Introduction
  • 7.17.4 Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.17.5 Torrent Pharmaceuticals Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details